| # | % | |||||
|---|---|---|---|---|---|---|
| 201 | HALOZYME THERAPEUTICS INC | 60,000 | 568,000 | 0.03% | ||
| 202 | RELYPSA INC | 415 | 562,000 | 0.03% | Put | |
| 203 | STRATA SKIN SCIENCES INC | 573,077 | 542,000 | 0.03% | ||
| 204 | BLUEPRINT MEDICINES CORP COM | 29,624 | 535,000 | 0.03% | ||
| 205 | NOVAVAX INC | 1,025 | 529,000 | 0.03% | Call | |
| 206 | REVANCE THERAPEUTICS INC | 302 | 527,000 | 0.03% | Call | |
| 207 | SUPERCONDUCTOR TECHNOLOGIES | 2,734,500 | 523,000 | 0.03% | ||
| 208 | BARCLAYS BK PLC IPATH S&P MT ETN | 479 | 521,000 | 0.03% | Call | |
| 209 | CAPRICOR THERAPEUTICS INC | 202,083 | 513,000 | 0.03% | ||
| 210 | ALKERMES PLC | 15,000 | 513,000 | 0.03% | ||
| 211 | CIDARA THERAPEUTICS INC | 40,277 | 512,000 | 0.03% | ||
| 212 | AMICUS THERAPEUTICS INC COM | 59,324 | 501,000 | 0.03% | ||
| 213 | ALCOBRA LTD | 1,312 | 497,000 | 0.02% | Call | |
| 214 | ADVAXIS INC | 537 | 485,000 | 0.02% | Put | |
| 215 | GILEAD SCIENCES INC | 50 | 459,000 | 0.02% | Put | |
| 216 | INSMED INC | 35,867 | 454,000 | 0.02% | ||
| 217 | NOVAVAX INC | 880 | 454,000 | 0.02% | Put | |
| 218 | SENSEONICS HOLDINGS INC | 153,900 | 440,000 | 0.02% | ||
| 219 | CESCA THERAPEUTICS INC COM NEW | 111,094 | 432,000 | 0.02% | ||
| 220 | FLEXION THERAPEUTICS INC | 46,355 | 426,000 | 0.02% | ||
| 221 | NEWLINK GENETICS CORP | 231 | 420,000 | 0.02% | Put | |
| 222 | EDAP TMS SA | 1,018 | 409,000 | 0.02% | Put | |
| 223 | SPECTRANETICS CORP | 279 | 405,000 | 0.02% | Call | |
| 224 | EAGLE PHARMACEUTICALS INC COM | 10,000 | 405,000 | 0.02% | ||
| 225 | EAGLE PHARMACEUTICALS INC | 100 | 405,000 | 0.02% | Put | |
| 226 | PLURISTEM THERAPEUTICS INC | 251,020 | 404,000 | 0.02% | ||
| 227 | INSPIREMD INC | 790,538 | 399,000 | 0.02% | ||
| 228 | REGULUS THERAPEUTICS INC | 574 | 398,000 | 0.02% | Put | |
| 229 | TROVAGENE INC | 85,000 | 395,000 | 0.02% | ||
| 230 | VALEANT PHARMACEUTICALS INTL | 149 | 392,000 | 0.02% | Call | |
| 231 | Axovant Sciences LTD | 34,040 | 391,000 | 0.02% | ||
| 232 | ELEVEN BIOTHERAPEUTICS INC | 1,213,984 | 387,000 | 0.02% | ||
| 233 | THRESHOLD PHARMACEUTICAL INC | 837,904 | 385,000 | 0.02% | ||
| 234 | INSMED INC | 296 | 375,000 | 0.02% | Call | |
| 235 | LIPOCINE INC NEW | 350 | 355,000 | 0.02% | Call | |
| 236 | HISTOGENICS CORP | 150,630 | 345,000 | 0.02% | ||
| 237 | SKYLINE MED INC | 2,001,348 | 345,000 | 0.02% | ||
| 238 | Pieris Pharmaceuticals | 175,000 | 333,000 | 0.02% | ||
| 239 | THERAPEUTICSMD INC | 511 | 327,000 | 0.02% | Call | |
| 240 | ZOSANO PHARMA CORP | 128,600 | 296,000 | 0.01% | ||
| 241 | BIODELIVERY SCIENCES INTL IN | 912 | 295,000 | 0.01% | Call | |
| 242 | IONIS PHARMACEUTICALS INC COM | 7,002 | 284,000 | 0.01% | ||
| 243 | PARATEK PHARMACEUTICALS INC | 186 | 282,000 | 0.01% | Call | |
| 244 | CELATOR PHARMACEUTICALS INC | 25,000 | 276,000 | 0.01% | ||
| 245 | PROVECTUS | 726,200 | 275,000 | 0.01% | ||
| 246 | CHIMERIX INC | 53,620 | 274,000 | 0.01% | ||
| 247 | VERTEX PHARMACEUTICALS INC | 33 | 262,000 | 0.01% | Put | |
| 248 | ARBUTUS BIOPHARMA CORP | 630 | 260,000 | 0.01% | Call | |
| 249 | THERAPEUTICSMD INC | 404 | 259,000 | 0.01% | Put | |
| 250 | CLOVIS ONCOLOGY INC | 13,326 | 256,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-101848, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
